MILabs Scientific Event at the SNMMI 2022

MILabs speakers snmmi v2

6.45  Synergetic Ultra-high Definition PET, SPECT, X-ray, and Optical CT – Prof. Freek Beekman, PhD, CEO MILabs, the Netherlands
7.05  Theranostics agents for immunomodulation and the critical role of quantitative imaging – Reinier Hernandez PhD, University of Wisconsin, USA
7.25  Targeted Multi-Modality Molecular Imaging for Cancer Theranostics: Three is Better than One! – Simone Dalm, PhD, Erasmus Medical Center, Rotterdam, The Netherlands

Scroll to Top